Orbital Compression Syndrome Mimicking Severe Malaria in a Child with Sickle Cell Disease in a Ugandan Refugee Settlement: A Case Report Authors: James Nelson Okema, Stephenson Ocen Oryem, Lydia Joyce Atto, Jude Ocen Okello, Jael Mary Nalukenge, Grace Acomo, Ronald Obal, Joel Atim Abong Published: 2026 ABSTRACT AbstractBackgroundOrbital compression syndrome (OCS) is a rare, sight-threatening complication of sickle cell disease (SCD), caused by vaso-occlusive infarction of orbital bone marrow with subperiosteal hematoma formation. Its presentation overlaps with orbital cellulitis and severe malaria, creating diagnostic uncertainty in resource-limited humanitarian settings.Case PresentationA 9-year-old boy with homozygous SCD (HbSS) presented to a primary health facility in Palabek Kal refugee settlement, Lamwo District, northern Uganda, with a 1-day history of sudden severe bilateral frontal headache radiating to the eyes, high-grade fever, and rapidly progressive bilateral periorbital edema, epiphora, and photophobia, without altered consciousness, seizures, vomiting, or respiratory distress. He was febrile (39.3°C) and unwell, with bilateral periorbital swelling, mild scleral icterus, and hepatomegaly (approximately 6 cm below the right costal margin); visual acuity, pupillary responses, extraocular movements, and proptosis assessment were normal. Laboratory evaluation showed severe anemia (hemoglobin 6.5 g/dL), leukocytosis (14.81 × 103/µL), and 3+ malaria parasitemia. Orbital imaging and cultures were unavailable. The clinical picture was most consistent with OCS secondary to vaso-occlusive crisis, with severe malaria, orbital cellulitis, and septicemia considered as concurrent or alternative diagnoses.Management and OutcomeThe child received intravenous artesunate, empirical broad-spectrum antibiotics, intravenous fluids, analgesics, and one unit of blood transfusion for severe anemia, with close ophthalmic monitoring. Fever resolved, periorbital swelling subsided, and visual function was preserved without surgical intervention.ConclusionThis case illustrates the diagnostic challenge of OCS in a child with SCD in a malaria-endemic humanitarian setting. OCS should be considered in any child with SCD presenting with acute bilateral periorbital swelling, headache, and fever, even when malaria is confirmed and orbital imaging is unavailable. Early recognition, parallel management of competing diagnoses, close clinical monitoring, and expanded access to orbital imaging in humanitarian settings are critical to prevent avoidable visual morbidity.Keywords: orbital compression syndrome, sickle cell disease, pediatric, refugee settlement, humanitarian setting, Uganda, malaria, periorbital swelling, differential diagnosis Introduction Orbital compression syndrome (OCS), also referred to in the sickle cell disease (SCD) literature as orbital infarction syndrome, is an uncommon but potentially sight-threatening complication of vaso-occlusive disease. During a vaso-occlusive crisis, sickling of red blood cells obstructs the microvasculature supplying the haematopoietically active marrow of the orbital bones; the resulting ischemic infarction disrupts adjacent small vessels and triggers hemorrhage into the subperiosteal space, producing a subperiosteal hematoma and periorbital edema.1,2 In severe cases, this process may result in optic nerve compression and permanent visual loss. The condition is clinically important because its presentation can overlap with more common orbital and systemic emergencies, including orbital cellulitis, pre-septal cellulitis, and malaria-related illness.3,4 This overlap creates diagnostic uncertainty, particularly in children with SCD presenting with fever and acute periorbital swelling, and OCS remains rare enough that clinicians outside specialist centers may not readily consider it in the differential diagnosis.4 The diagnostic challenge is greater in malaria-endemic, resource-limited settings, where access to orbital imaging (computed tomography or magnetic resonance imaging) – usually required to confirm subperiosteal hematoma and exclude orbital abscess – and specialist ophthalmic assessment may be limited.4 In such contexts, clinicians must often rely on clinical evaluation while simultaneously considering infectious and non-infectious causes. Published reports have described OCS in children with SCD across various regions, including recent cases from Uganda;1,3,5–7 however, reports from humanitarian refugee settlements in sub-Saharan Africa remain limited. We report a case of a 9-year-old boy with SCD presenting with acute bilateral periorbital swelling in Palabek Kal refugee settlement, Lamwo District, northern Uganda. The case highlights the diagnostic overlap between OCS, malaria, and orbital infection, and emphasizes the need for structured clinical assessment and parallel management in settings where diagnostic resources are constrained. This case report follows the CARE (CAse REport) guideline for reporting case reports,8 and compliance with the checklist is summarized in Table A1 and (Supplementary Material). Patient Information A 9-year-old male South Sudanese refugee, residing in Palabek Kal refugee settlement, Lamwo District, northern Uganda, presented with a 1-day history of sudden-onset severe bilateral frontal headache radiating to both eyes. The headache was associated with high-grade fever and was followed within hours by progressive bilateral periorbital swelling, epiphora, and photophobia. The onset was abrupt, and the caregiver described the pain as unusually severe compared with previous vaso-occlusive episodes. There was no history of cough, dyspnea, vomiting, diarrhea, convulsions, altered consciousness, neck stiffness, rash, facial trauma, sinusitis, dental pain, or recent upper respiratory tract infection. The child had a known diagnosis of homozygous sickle cell disease (HbSS) established in early childhood. He had experienced prior vaso-occlusive pain episodes but had no documented history of orbital involvement, stroke, or acute chest syndrome. He was not receiving hydroxyurea therapy and had not undergone recent blood transfusion. Vaccination history was incompletely documented. He attended school within the settlement. No family history of ocular disease was reported. Regular medications included folic acid supplementation and penicillin V prophylaxis. No drug allergies were documented. Clinical Findings On presentation, the child appeared acutely unwell. Temperature was 39.3°C. He was alert, oriented, and in mild-to-moderate distress. Ocular examination demonstrated bilateral periorbital edema, more prominent in the upper eyelids, with associated epiphora and photophobia (Figure 1). No purulent discharge was observed. The eyelids were swollen but soft, with no detectable fluctuance. Visual acuity, pupillary responses, extraocular movements, proptosis assessment, and conjunctival examination were all normal. Periorbital region at presentation in a 9-year-old child with homozygous sickle cell disease (HbSS), cropped to the periorbital region to minimize identifiability. Note the symmetric upper eyelid swelling, epiphora, and absence of purulent discharge, consistent with a non-suppurative orbital process. Written informed consent for publication of this identifiable clinical photograph was obtained from the patient’s parent/legal guardian. General examination revealed mild scleral icterus and clinical features consistent with severe anemia. No cyanosis, peripheral edema, or lymphadenopathy was detected. Cardiovascular examination showed normal heart sounds without murmurs; capillary refill time was within normal limits. Respiratory examination was normal, with bilateral vesicular breath sounds and no added sounds. Abdominal examination showed mild distension; the liver was palpable approximately 6 cm below the right costal margin in the mid-clavicular line. Splenomegaly was not clearly detected. Bowel sounds were present and ascites was absent. Neurological examination demonstrated a Glasgow Coma Scale score of 15/15 with no focal neurological deficits. Timeline Table 1 presents the chronological sequence of events from the day before symptom onset through initial treatment and outcome. Table 1Clinical TimelineTime PointEventDetailsDay −1Premorbid stateChild well at baseline; taking regular folic acid and penicillin V. Living in Palabek Kal refugee settlement.Day 1 (Hour 0)Symptom onsetSudden-onset severe bilateral frontal headache radiating to the eyes. High-grade fever (39.3°C) develops within hours.Day 1 (Hour 2–6)Rapid progressionProgressive bilateral periorbital swelling, epiphora, and photophobia. No alteration of consciousness, seizures, or vomiting.Day 1 (presentation)Clinical assessmentExamination at Palabek Kal Health Centre IV: fever, bilateral periorbital edema, mild scleral icterus, hepatomegaly (~6 cm below RCM), GCS 15/15. No purulent discharge, no fluctuance.Day 1 (same day)InvestigationsFBC: Hb 6.5 g/dL, Hct 20.5%, WBC 14.81 × 103/µL, Platelets 338 × 103/µL. Malaria smear: 3+ parasitemia. RBG: normal. Renal/liver function, blood culture, and orbital imaging unavailable.Day 1–2Treatment initiatedIV artesunate commenced (severe malaria); IV broad-spectrum antibiotics (empirical, covering orbital cellulitis and bacteremia); IV fluids (hydration and anti-sickling); analgesics; 1 unit blood transfusion (severe anemia); oral folic acid continued.Day 2–3Early responseFever begins to resolve. Periorbital swelling begins to decrease. Serial ophthalmic checks: no progressive proptosis or visual deterioration.Day 3–5Continued improvementPeriorbital swelling progressively subsides. Malaria parasitemia clears. Transition to oral antimalarial therapy planned. No signs of optic nerve compromise.DischargeClinical stabilizationChild discharged after clinical stabilization. Visual function preserved; no operative intervention required. Follow-up arranged for ophthalmic and hematologic review. Clinical Timeline Diagnostic Assessment Investigations On admission, the following investigations were requested: full blood count (FBC), malaria blood film, random blood glucose (RBG), renal function tests (RFTs), liver function tests (LFTs), blood culture, and orbital assessment. The child’s known HbSS genotype was confirmed from prior records. The FBC revealed severe anemia with a hemoglobin of 6.5 g/dL and hematocrit of 20.5%, leukocytosis (WBC 14.81 × 103/µL), and a platelet count of 338 × 103/µL. The malaria blood smear was strongly positive with parasitemia graded as 3+. Random blood glucose was within the normal range. Renal function tests, liver function tests, blood cultures, and orbital imaging were not performed because they were unavailable at the presenting facility, limiting assessment of systemic organ dysfunction, bacteremia, and radiologic confirmation of OCS. Diagnostic Reasoning The leading diagnosis was orbital compression syndrome in the setting of sickle cell disease. The sudden onset of severe bilateral frontal headache, bilateral periorbital swelling, fever, and the underlying HbSS genotype were strongly consistent with a vaso-occlusive orbital event. The bilateral nature of the periorbital swelling made orbital cellulitis less likely, as cellulitis characteristically presents unilaterally. The absence of purulent discharge, fluctuance, and documented trauma further reduced the likelihood of a primary suppurative process. Severe malaria was considered a concurrent rather than alternative diagnosis: the child resided in a high-transmission malaria-endemic zone, the blood smear was strongly positive (3+), and systemic features including jaundice, hepatomegaly, and severe anemia supported concurrent malaria infection and hemolysis. Septicemia remained an important differential consideration given the child’s functional asplenia and susceptibility to invasive bacterial infection.9 Table 2 presents the differential diagnosis framework applied in this case. Table 2Differential Diagnosis FrameworkDiagnosisSupporting FeaturesStatusLikelihoodDiscriminating FactorOrbital Compression Syndrome (SCD)Bilateral periorbital edema, severe frontal headache, fever, known HbSS, hepatomegaly, jaundiceLEADING DIAGNOSIS*HighOrbital imaging; response to transfusion/analgesicsOrbital CellulitisPeriorbital swelling, fever, eye pain; cannot be excluded without imagingImportant differentialModerateCT orbit; unilateral presentation expected; lack of proptosis/restricted EOM reduces likelihoodSevere Malaria (± ocular)Fever, headache, jaundice, hepatomegaly, endemic setting, SCD vulnerability, 3+ parasitemiaConcurrent/co-diagnosisHighMalaria smear/RDT; parasite density; separate from orbital mechanismSepticemiaFever, ill-appearing, hepatomegaly, systemic signs; functional asplenia riskDifferentialModerateBlood culture; response to antibioticsCavernous Sinus ThrombosisBilateral orbital signs, headache, feverRare differentialLowCT/MRI brain and venography; clinical examinationOrbital Lymphoma/Leukemic DepositPeriorbital swelling, headache; SCD does not preclude haematological malignancyRemote differentialVery LowCBC with differential; bone marrow examination; orbital imagingNotes: *Bold text (“LEADING DIAGNOSIS”) indicates the diagnosis considered most likely on the basis of the overall clinical, laboratory, and course-of-illness findings at the time of assessment; it does not denote a radiologically confirmed diagnosis, as orbital imaging was unavailable in this case. Differential Diagnosis Framework Notes: *Bold text (“LEADING DIAGNOSIS”) indicates the diagnosis considered most likely on the basis of the overall clinical, laboratory, and course-of-illness findings at the time of assessment; it does not denote a radiologically confirmed diagnosis, as orbital imaging was unavailable in this case. Given the substantial overlap between these conditions and the limited availability of confirmatory investigations, a parallel diagnostic and therapeutic approach was adopted. Therapeutic Intervention Immediate Resuscitation and Supportive Care On arrival, intravenous access was secured and supportive care commenced. Isotonic intravenous fluids were administered to maintain hydration, reduce sickling risk, and support circulation. Vital signs, urine output, and general clinical status were monitored closely throughout admission. Treatment of Severe Malaria Intravenous artesunate was commenced for severe malaria in accordance with World Health Organization treatment guidelines.10 Antipyretics were administered for fever control. Transition to oral artemisinin-based combination therapy was planned once clinical improvement allowed oral intake. Blood Transfusion One unit of blood transfusion was administered for severe anemia (hemoglobin 6.5 g/dL) in the context of sickle cell disease and acute systemic illness. The transfusion aimed to improve oxygen-carrying capacity and reduce the risk of further vaso-occlusive deterioration. No transfusion reaction was reported. Antibiotic and Analgesic Therapy Empirical broad-spectrum intravenous antibiotics were administered to cover the possibility of orbital cellulitis and other bacterial infection, given the diagnostic uncertainty and the child’s functional asplenic state. Analgesics were provided for pain control. Oral folic acid was continued as part of routine sickle cell disease management. Ophthalmic Monitoring Serial ophthalmic assessments were performed during admission, focusing on visual symptoms, pupillary responses, extraocular movements, and progression of periorbital swelling. The child was monitored for signs of optic nerve compromise or worsening orbital pressure. No surgical intervention was required. Follow-Up and Outcomes Following treatment, the child improved clinically. Fever resolved and periorbital swelling gradually subsided over the course of admission. Malaria parasitemia cleared with artesunate therapy, and the child remained visually stable with no documented loss of visual acuity. He completed inpatient management without operative intervention and was discharged after clinical stabilization on appropriate antimalarial therapy, supportive medications, and routine sickle cell disease care. Follow-up was arranged for continued ophthalmic and hematologic review. Patient Perspective The caregiver reported significant anxiety at presentation, primarily relating to the child’s bilateral eye swelling, high fever, and concern about possible permanent visual loss. Following treatment and clinical improvement, the caregiver expressed relief at the child’s recovery and gratitude for the care received at the health facility. The caregiver stated willingness to seek medical attention promptly if similar symptoms recur in the future. Discussion We report a child with homozygous sickle cell disease presenting with acute bilateral periorbital swelling, severe frontal headache, fever, epiphora, and photophobia in a humanitarian refugee settlement in northern Uganda. The clinical presentation, in the context of HbSS, was most consistent with orbital compression syndrome. However, the absence of orbital imaging limits diagnostic confirmation, and the diagnosis should be interpreted as clinically supported rather than radiologically confirmed. This case highlights a key clinical problem: acute bilateral periorbital swelling in a child with SCD can represent a vaso-occlusive orbital event even in malaria-endemic settings where fever may initially bias clinicians toward infection. Coexisting malaria parasitemia and systemic features increase the risk of diagnostic anchoring. Crucially, the presence of malaria does not exclude a concurrent sickle cell–related complication, and both processes may occur simultaneously.11 Orbital compression syndrome is thought to result from vaso-occlusion within the marrow of the orbital bones, leading to infarction, subperiosteal hemorrhage, and soft tissue swelling.2–4 Children are more commonly affected because of the persistence of haematopoietically active marrow in the craniofacial bones. The condition often presents with headache, eyelid swelling, and fever, all of which overlap with orbital cellulitis.1,3,4 A recent systematic review of orbital involvement in SCD confirms that periorbital swelling, fever, and headache are among the most frequently reported presenting features, and that computed tomography or magnetic resonance imaging remains central to distinguishing OCS from orbital cellulitis and other orbital space-occupying processes.4 This overlap creates a significant diagnostic challenge when imaging is unavailable, as in the present case. In this case, several features favored a vaso-occlusive process. The presentation was bilateral and acute, occurring in a child with known SCD in the absence of sinusitis, trauma, dental infection, or purulent discharge. These findings reduced the likelihood of a primary suppurative orbital infection. However, orbital cellulitis could not be excluded without imaging, justifying empirical antimicrobial therapy. The coexistence of malaria further complicated the diagnostic process. Fever, hepatomegaly, jaundice, severe anemia, and confirmed parasitemia (3+) supported concurrent malaria infection but did not explain the bilateral orbital involvement. Leukocytosis was consistent with systemic illness but was not specific for bacterial infection. Given the child’s functional asplenia and the well-documented risk of invasive bacterial infection in children with SCD, particularly in sub-Saharan Africa,9 septicemia remained an important consideration, justifying empirical antibiotic cover. Management in this case required simultaneous treatment of multiple potential conditions. Antimalarial therapy was initiated for confirmed parasitemia, supportive care and blood transfusion were provided for vaso-occlusive disease and severe anemia, and empirical antibiotics covered possible orbital cellulitis and bacteremia. This reflects pragmatic decision-making in settings where diagnostic certainty is limited but the consequences of delayed treatment are significant.12 The absence of orbital imaging is a key limitation. Computed tomography is useful for identifying subperiosteal hematoma and excluding orbital abscess formation, but it was unavailable at the point of care.13 This reflects a broader constraint in many humanitarian and low-resource settings. Despite this limitation, the patient improved with conservative management and close monitoring, and no features of progressive orbital or neurologic compromise were documented. Previous reports of OCS in SCD describe similar presentations with bilateral periorbital swelling and headache in pediatric patients, including two recent cases managed in Uganda that similarly required a broad differential diagnosis and empirical multimodal treatment in the absence of readily available orbital imaging.3,5–7 This case adds to the existing literature by describing OCS in a humanitarian refugee settlement in sub-Saharan Africa and demonstrating the additional diagnostic complexity introduced by concurrent malaria, a combination not previously described in the reported Ugandan cases.6,7 The case underscores the need for structured clinical approaches that consider both infectious and vaso-occlusive causes in children with SCD presenting with orbital symptoms. This report has several limitations. Orbital imaging was not performed; therefore, subperiosteal hemorrhage could not be confirmed radiologically. Documentation of detailed ophthalmic findings, including formal quantitative visual acuity testing and fundoscopy, was limited by resource constraints, although bedside assessment of visual acuity, pupillary responses, extraocular movements, and proptosis was normal and is reported above. Complete vital signs and serial laboratory data could not be reported in full. These limitations are inherent to emergency care in humanitarian settings and should be considered when interpreting the diagnosis and outcome. Conclusion Orbital compression syndrome should be considered in children with sickle cell disease who present with acute bilateral periorbital swelling, headache, and fever. In malaria-endemic settings, confirmed malaria parasitemia does not exclude a concurrent vaso-occlusive orbital complication. Where diagnostic resources are limited, a parallel management strategy addressing both infectious and non-infectious causes is appropriate. Early recognition and close clinical monitoring are essential to reduce the risk of visual morbidity in these vulnerable patients. Strengthening access to orbital imaging and ophthalmic support in humanitarian and other resource-limited settings would further improve the timely diagnosis and management of this rare but potentially sight-threatening complication.